HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1936 Cr | ₹8737 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.14 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -0.12% | 0.47% |
6 Month | 14.93% | 12.35% |
1 Year | 13.51% | 2.89% |
3 Year | - | 23.86% |
5 Year | - | 18.53% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 6.63% | 4.46% |
1 Year | 15.08% | 7.63% |
3 Year | - | 22.46% |
5 Year | - | 18.88% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 29.56% | 17.31% |
3 Year | - | 20.52% |
5 Year | - | 20.64% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 14.61% |
Sharp | - | 1.14% |
Beta | - | 0.90% |
Alpha | - | 0.72% |
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Funds Managed | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 8.44 | 1.47 |
Mid Cap | 24.57 | 32.06 |
Small Cap | 37.01 | 31.79 |
Large Cap | 29.99 | 34.68 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.8 | 0.55 |
Basic Materials | 2.27 | - |
Healthcare | 95.93 | 99.45 |
Top Comparisons
Tata Large & Mid Cap Fund- Regular Plan - Growth Option
3Y Returns15.56%
DSP Large & Mid Cap Fund - Regular Growth
3Y Returns20.34%
ITI Small Cap Fund Regular - Growth
3Y Returns27.69%
Sundaram Small Cap Fund Regular Plan - Growth
3Y Returns21.36%
Tata Money Market Fund-Regular Plan - Growth Option
3Y Returns7.5%
Mirae Asset Money Market Fund Regular Growth
3Y Returns7.1%
ICICI Prudential Multicap Fund - Growth
3Y Returns21.18%
DSP Multicap Fund - Regular (G)
3Y Returns0%